Yu Yong

Chief Scientific Officer at GNLX

Sold, on record
$3.3M
Dollars the filings state
Form 4 sales
19
Latest Aug 31, 2026
Form 144 notices
11
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • GNLXGENELUX CorpChief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
3
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale GNLXUnusual
    Dec 15, 2023 2023

    Sold 32,535 shares at $13.16 ($428k)

    Yu Yong, VP, Clinical Trial Operations

    No 10b5-1 planSold 100% of holdings ($428k position)0 shares left3.1x usual sizeFollows a Form 144Filing

  2. 2 Form 4 sale GNLXUnusual
    Jun 24, 2024 +192 days

    Sold 6,849 shares at $2.12 ($15k)

    Yu Yong, VP, Clinical Trial Operations

    No 10b5-1 planSold 38.7% of holdings ($38k position)10,869 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale GNLXNo plan
    May 12, 2025 +322 days

    Sold 5,579 shares at $2.92 ($16k)

    Yu Yong, VP, Clinical Trial Operations

    No 10b5-1 planSold 10.5% of holdings ($155k position)47,640 shares left0.5x usual sizeFiling

  4. 4 Form 4 sale GNLXNo plan
    Nov 17, 2025 +189 days

    Sold 4,192 shares at $3.83 ($16k)

    Yu Yong, SVP, Clinical Development

    No 10b5-1 planSold 2.8% of holdings ($574k position)145,844 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale GNLXNo plan
    Mar 24, 2026 +127 days

    Sold 906 shares at $2.42 ($2k)

    Yu Yong, SVP, Clinical Development

    No 10b5-1 planSold 0.6% of holdings ($353k position)144,938 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale GNLXNo plan
    May 11, 2026 +48 days

    Sold 605 shares at $2.97 ($2k)

    Yu Yong, Chief Scientific Officer

    No 10b5-1 planSold 0.4% of holdings ($446k position)149,706 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale GNLXNo plan
    Aug 4, 2026 +85 days

    Sold 653 shares at $2.94 ($2k)

    Yu Yong, Chief Scientific Officer

    No 10b5-1 planSold 0.2% of holdings ($791k position)268,371 shares left0.3x usual sizeFiling

  8. 8 Form 4 sale GNLXUnusual
    Aug 31, 2026 +27 days

    Sold 9,683 shares at $2.75 ($27k)

    Yu Yong, Chief Scientific Officer

    No 10b5-1 planSold 3.6% of holdings ($738k position)258,688 shares left10.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (30)

Form 144 notices and Form 4 sales by Yu Yong
Source
Aug 31, 2026Sep 2, 2026GNLXChief Scientific OfficerForm 4 sale9,683$27k3.6%UnusualSEC
Aug 4, 2026Aug 4, 2026GNLXChief Scientific OfficerForm 4 sale653$2k0.2%No planSEC
May 11, 2026May 12, 2026GNLXChief Scientific OfficerForm 4 sale605$2k0.4%No planSEC
Mar 24, 2026Mar 26, 2026GNLXSVP, Clinical DevelopmentForm 4 sale906$2k0.6%No planSEC
Nov 17, 2025Dec 11, 2025GNLXSVP, Clinical DevelopmentForm 4 sale4,192$16k2.8%No planSEC
May 12, 2025May 13, 2025GNLXVP, Clinical Trial OperationsForm 4 sale5,579$16k10.5%No planSEC
Jun 24, 2024Jul 8, 2024GNLXVP, Clinical Trial OperationsForm 4 sale6,849$15k38.7%UnusualSEC
Dec 15, 2023Dec 18, 2023GNLXVP, Clinical Trial OperationsForm 4 sale32,535$428k100.0%UnusualSEC
Dec 15, 2023Dec 15, 2023GNLXOfficerForm 144 notice32,535$428kNoticeSEC
Dec 7, 2023Dec 8, 2023GNLXVP, Clinical Trial OperationsForm 4 sale36,800$436k53.1%UnusualSEC
Dec 7, 2023Dec 7, 2023GNLXOfficerForm 144 notice36,800$436kNoticeSEC
Nov 21, 2023Nov 22, 2023GNLXVP, Clinical Trial OperationsForm 4 sale18,665$192k21.2%UnusualSEC
Nov 20, 2023Nov 21, 2023GNLXVP, Clinical Trial OperationsForm 4 sale18,135$211k17.1%UnusualSEC
Nov 17, 2023Nov 17, 2023GNLXOfficerForm 144 notice36,800$479kNoticeSEC
Oct 24, 2023Oct 25, 2023GNLXVP, Clinical Trial OperationsForm 4 sale5,200$99k4.7%No planSEC
Oct 24, 2023Oct 24, 2023GNLXOfficerForm 144 notice5,200$101kNoticeSEC
Oct 10, 2023Oct 11, 2023GNLXVP, Clinical Trial OperationsForm 4 sale5,200$114k4.7%No planSEC
Oct 10, 2023Oct 10, 2023GNLXOfficerForm 144 notice5,200$124kNoticeSEC
Sep 26, 2023Sep 27, 2023GNLXVP, Clinical Trial OperationsForm 4 sale5,200$123k4.7%No planSEC
Sep 26, 2023Sep 26, 2023GNLXOfficerForm 144 notice5,200$130kNoticeSEC
Sep 20, 2023Sep 21, 2023GNLXVP, Clinical Trial OperationsForm 4 sale6,000$168k5.4%No planSEC
Sep 20, 2023Sep 20, 2023GNLXOfficerForm 144 notice6,000$165kNoticeSEC
Sep 15, 2023Sep 18, 2023GNLXVP, Clinical Trial OperationsForm 4 sale10,400$228k8.9%No planSEC
Sep 15, 2023Sep 15, 2023GNLXOfficerForm 144 notice10,400$230kNoticeSEC
Sep 13, 2023Sep 15, 2023GNLXVP, Clinical Trial OperationsForm 4 sale29,800$630k21.9%No planSEC
Sep 13, 2023Sep 13, 2023GNLXOfficerForm 144 notice29,800$630kNoticeSEC
Aug 30, 2023Aug 30, 2023GNLXOfficerForm 144 notice19,800$489kNoticeSEC
Aug 30, 2023Aug 30, 2023GNLXVP, Clinical Trial OperationsForm 4 sale19,800$489k12.7%No planSEC
Aug 18, 2023Aug 22, 2023GNLXVP, Clinical Trial OperationsForm 4 sale3,265$77k2.1%No planSEC
Aug 18, 2023Aug 18, 2023GNLXOfficerForm 144 notice3,274$78kNoticeSEC